Skip to main content
Log in

Warfarin more cost effective than oral anticoagulants

PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. 2015 US dollars

Reference

  • Hospodar AR, et al. Comparing the Cost Effectiveness of Non-vitamin K Antagonist Oral Anticoagulants with Well-Managed Warfarin for Stroke Prevention in Atrial Fibrillation Patients at High Risk of Bleeding. American Journal of Cardiovascular Drugs : 9 May 2018. Available from: URL: http://doi.org/10.1007/s40256-018-0279-y

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Warfarin more cost effective than oral anticoagulants. PharmacoEcon Outcomes News 803, 31 (2018). https://doi.org/10.1007/s40274-018-4958-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-018-4958-3

Navigation